Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

Overview of attention for article published in BMC Medicine, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 23 X posts from 18 X users, with an upper bound of 464,919 followers.

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration https://t.co/sKqsIlIUx5

Key guidelines to avoid pitfalls inherent in mathematical models from very high-dimensional omics data @BMCMedicine http://t.co/adQQzSjCJK

Key guidelines to avoid pitfalls inherent in mathematical models from very high-dimensional omics data @BMCMedicine http://t.co/adQQzSjCJK

Key guidelines to avoid pitfalls inherent in mathematical models from very high-dimensional omics data @BMCMedicine http://t.co/adQQzSjCJK

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.